About Us

Our research can be characterized by two primary interests:

  1. Identify the genetic lesions underlying cancer pathogenesis for each cancer patient.
  2. Identify specific, gene-targeted therapies that can be individually tailored to cancer patients on the basis of their causative oncogenic lesions.